Matsunaga Takeaki, Naganuma Ken, Tanabe Noriko, Mori Yoshiko, Nagata Marino, Momose Shuji, Kubota Yasushi
Department of Hematology, Saitama Medical Center Saitama Medical University Saitama Japan.
Department of Clinical Genetics, Saitama Medical Center Saitama Medical University Saitama Japan.
EJHaem. 2025 Apr 24;6(2):e1101. doi: 10.1002/jha2.1101. eCollection 2025 Apr.
In patients with X-linked agammaglobulinemia (XLA), serum immunoglobulins are almost completely lacking. The prevalence of autoimmune diseases is low in XLA compared with other primary immunodeficiency diseases because antibodies are absent in XLA. Immune thrombocytopenia (ITP) is considered an antibody-mediated disease characterized by increased platelet destruction, and adult-onset ITP in XLA has not been reported in detail. The case of a 29-year-old Japanese man with XLA and ITP is described. The patient was treated with prednisolone and intravenous immunoglobulins, resulting in rapid improvement of thrombocytopenia. Clinicians should consider co-existing ITP when progressive thrombocytopenia is observed in a patient with XLA.
在X连锁无丙种球蛋白血症(XLA)患者中,血清免疫球蛋白几乎完全缺乏。与其他原发性免疫缺陷病相比,XLA中自身免疫性疾病的患病率较低,因为XLA中缺乏抗体。免疫性血小板减少症(ITP)被认为是一种以血小板破坏增加为特征的抗体介导性疾病,而XLA中的成人发病型ITP尚未有详细报道。本文描述了一名29岁患有XLA和ITP的日本男性病例。该患者接受了泼尼松龙和静脉注射免疫球蛋白治疗,血小板减少症迅速改善。当在XLA患者中观察到进行性血小板减少时,临床医生应考虑合并存在ITP。